Skip to Content
Business Wire

Albendazole Market by Target Pathogen, End-use and Distribution Channel - Global Forecast up to 2026 - ResearchAndMarkets.com

Albendazole Market by Target Pathogen, End-use and Distribution Channel - Global Forecast up to 2026 - ResearchAndMarkets.com

The "Albendazole Market based on Target Pathogen, End-use and Distribution Channel and Geography - Global Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.

The Albendazole Market is projected to grow at the rate of 7.4% CAGR by 2026.

The albendazole market is significantly driven by one of the major factors: the rising prevalence of worm infestations majorly in the rural and underdeveloped areas. Along with that, the inadequacy of drinking water, dearth of cleanliness, and lack of permitted sanitation in few areas are the reasons responsible for the rising number of parasitic worms, which eventually increase the requirement of albendazole around the world.

Albendazole is a WHO-recommended prescription used for parasitic worm pervasive. It is an extensive range prescription, which is also known as albendazole. Albendazole is an orally taken medicine that is recognized as a significant and safe drug required for the health system.

It is very useful in conditions such as hydatid disease, giardiasis, filariasis, trichuriasis, neurocysticercosis, pinworm disease, and ascariasis, among others. On the other hand, the negative effects of albendazole drugs are likely to hamper the albendazole market growth potential.

Based on the target pathogen, the market is categorized into tapeworm, hookworm, pinworm, and others. The pinworm segment is expected to hold the major share in the market owing to the high possibility of infection through pinworms, specifically in children, which increases the demand for albendazole. The albendazole drug is considered effective medicine for killing pinworms.

Further, the market is segmented according to the end-use; again, the end-use segmentation is divided into Ascaris infection treatment, pinworm infection treatment, and others. The pinworm infection treatment is expected to dominate the albendazole market. This can be attributed to an increasing incidence of pinworm infections around the world, majorly in the underdeveloped areas where there is a lack of hygiene, inadequate drinking water, and lack of awareness about the importance of hygiene.

Distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and veterinary clinics. Online pharmacies are the significant distribution channel in the albendazole market due to the rising online purchases and the availability of various drugs in online pharmacies.

North American region is holding the highest share in the albendazole market. This is ascribed to the increasing focus on research and development activities by key players in this region and the rising incidence of pinworm infections in the U.S.

Globally, the increasing prevalence of helminths infections which are caused by roundworm, hookworm, and other worms, is anticipated to boost the demand for anthelmintic drugs for infection treatment. This factor, in turn, will contribute to the growth of the global market.

Moreover, the growing awareness regarding veterinary care raises the level of control and care of animals. This results in growth in the population of animals. Additionally, the improvements in veterinary education in the past few decades have placed greater importance on animal welfare, owing to which the demand for albendazole has increased in animal care.

The albendazole drug has been considered as the safe and crucial medicine around the world, which is required for the health system. Moreover, the governments of few developing countries are taking initiatives to tackle the increasing incidence of infectious diseases among rural areas.

Report Scope

Albendazole Market based on Target Pathogen

  • Tapeworm
  • Hookworm
  • Pinworm
  • Others

Albendazole Market based on End-use

  • Ascaris Infection Treatment
  • Pinworm Infection Treatment
  • Others

Albendazole Market based on Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Veterinary Clinics

Competitive Landscape

Company Profiles

  • Sequent Scientifi
  • Lasa Laboratory Pvt Ltd
  • CHANGZHOU YABANG
  • GlaxoSmithKline
  • MANAV DRUGS
  • Ashish life Science Pvt. Ltd.
  • Huazhong Pharmaceutical
  • K.A.Malle Pharmaceuticals
  • HUBEI KEYI
  • Fredun Pharmaceuticals Ltd

Companies to Watch

  • Salius Pharma
  • Leo Bio-Care Pvt.
  • Hubei Zhongjia-chem Pharmaceutical

Key Topics Covered:

1. Executive Summary

2. Industry Outlook

3. Market Snapshot

4. Market characteristics

5. Target Pathogen: Market Size & Analysis

6. End-Use: Market Size & Analysis

7. Distribution Channel: Market Size & Analysis

8. Geography: Market Size & Analysis

9. Competitive Landscape

10. Vendor Profiles

For more information about this report visit https://www.researchandmarkets.com/r/fe7ns8

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005727/en/

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.